In the BioHarmony Drug Report Database

"Preview" Icon

Epoetin theta

Biopoin, Eporatio (epoetin theta) is a protein pharmaceutical. Epoetin theta was first approved as Biopoin on 2009-10-23. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.

 

Trade Name

 

Biopoin, Eporatio
 

Common Name

 

epoetin theta
 

ChEMBL ID

 

CHEMBL2108290
 

Indication

 

anemia, chronic kidney failure, neoplasms
 

Drug Class

 

Erythropoietins

Image (chem structure or protein)

Epoetin theta structure rendering